http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3000419-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ce08fe8a4ef978a21143f754fd70f1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C50-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C50-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13d69a09a91be7dd3a3f86129f334df8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4833cb07f188a7e607e06d51ddcb838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fea7ad73daaca25fdc24a4797b3324f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ea6f787979ccc8c6971d18c65ea894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59fdaad6f1eb1febd5570bf70a195bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e800ee6ad6ec0879029c14c9a8f983
publicationDate 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3000419-A1
titleOfInvention Formulation of hypericin for photodynamic diagnosis
abstract A formulation which can be used as a photosensitizer in the early detection of cancer, for example bladder cancer, contains polyvinylpyrrolidone-bound or polyvinylpyrrolidone-complexed hypericin sodium salt.
priorityDate 2015-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137629134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20838006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422877634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200

Total number of triples: 44.